Lilly stock hit after safety trials halted
Analysts and investors turned sour on Eli Lilly and Co.’s stock overnight after the Indianapolis drug maker stopped enrolling patients in two small safety trials of a potential blockbuster drug. Lilly shares opened today at $52.15, down $3.74 or 6.6 percent from their close yesterday. Lilly announced yesterday after markets closed that it had temporarily […]